128 related articles for article (PubMed ID: 28777969)
21. Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential amphotericin B delivery matrix.
Richter AR; Carneiro MJ; de Sousa NA; Pinto VPT; Freire RS; de Sousa JS; Mendes JFS; Fontenelle ROS; Feitosa JPA; Paula HCB; Goycoolea FM; de Paula RCM
Int J Biol Macromol; 2020 Jun; 152():492-502. PubMed ID: 32097738
[TBL] [Abstract][Full Text] [Related]
22. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.
Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E
Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
24. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
25. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
26. Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B.
Pedroso LS; Khalil NM; Mainardes RM
Curr Drug Deliv; 2018; 15(7):1055-1063. PubMed ID: 29629661
[TBL] [Abstract][Full Text] [Related]
27. Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation.
Jain K; Verma AK; Mishra PR; Jain NK
Antimicrob Agents Chemother; 2015 May; 59(5):2479-87. PubMed ID: 25645852
[TBL] [Abstract][Full Text] [Related]
28. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
Carraro TC; Khalil NM; Mainardes RM
Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
30. Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles.
Tiyaboonchai W; Woiszwillo J; Middaugh CR
J Pharm Sci; 2001 Jul; 90(7):902-14. PubMed ID: 11458338
[TBL] [Abstract][Full Text] [Related]
31. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
32. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
33. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
[TBL] [Abstract][Full Text] [Related]
34. Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability.
Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Valizadeh H; Maniruzzaman M; Farmoudeh A; Nokhodchi A
AAPS PharmSciTech; 2017 Jul; 18(5):1469-1474. PubMed ID: 27834054
[TBL] [Abstract][Full Text] [Related]
35. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
Tripathi P; Jaiswal AK; Dube A; Mishra PR
Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750
[TBL] [Abstract][Full Text] [Related]
36. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.
Yang Z; Tan Y; Chen M; Dian L; Shan Z; Peng X; Wu C
AAPS PharmSciTech; 2012 Dec; 13(4):1483-91. PubMed ID: 23090113
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach.
Usman F; Ul-Haq Z; Khalil R; Tinpun K; Srichana T
J Pharm Sci; 2017 Dec; 106(12):3574-3582. PubMed ID: 28847478
[TBL] [Abstract][Full Text] [Related]
38. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier.
Wang J; Tang J; Zhou X; Xia Q
Drug Dev Ind Pharm; 2014 Feb; 40(2):201-10. PubMed ID: 23336811
[TBL] [Abstract][Full Text] [Related]
40. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]